Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 28, 2014
Pharmacy Choice - News - Generic Drugs - November 28, 2014

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 44     Next >>     Go To Page:

11/28/14 - Tiered Pricing - What Pharmaceutical Companies Can Do to Improve Access to Medicines and Vaccines
While making medicines and vaccines more affordable won't on its own solve the problem of access to medicines- many of the medicines and vaccines that children need already have high-quality, inexpensive generic versions- when it comes to making sure children benefit from the newest and most innovative medicines and vaccines, affordability is criti
11/27/14 - NHS Framework for the supply of Generic Pharmaceuticals Wave 9c. [TendersInfo (India)]
Contract notice: NHS Framework for the supply of Generic Pharmaceuticals Wave 9 c. Potential periods of call-offs under the framework agreement: 100% oral products: All regions 1.7. 2015 to 28.2. 2017 33% hospital only products: DLN/DNW 1.7. 2015 to 30.6. 2017 Housekeeping products: DLS/DNE 1.7. 2015 to 29.2. 2016 and DCE/DSW 1.7. 2015 to 31.10. 20
11/27/14 - Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
SWOT, Economic and Business Environment specifics include:? Key strengths, weaknesses and threats influencing leading player position within the market? Top Five Contract Pharmaceutical Export Markets of China? Major players within China's leading therapeutic markets? Multinational penetration into the Chinese Pharma Market? Comprehensive
11/27/14 - Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines
"PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients, Contract Research and Manufacturing Services, Biosimilars, Generics& Vaccines" by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report describes
11/27/14 - Teva announces new chairman
Israeli pharma giant Teva yesterday elected Yitzhak Peterburg as its chairman, succeeding Phillip Frost, who is due to step down at the end of the year. Frost had wanted to steer Teva towards specialty pharmaceuticals while other board members wanted the world's biggest generic drugmaker to focus on its core business. Peterburg, with Teva since 200
11/27/14 - United States : Omnicare and McKesson Expand Distribution Agreement [TendersInfo (India)]
Omnicare Inc. and McKesson Corporation announced the signing of an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. As part of the expanded agreement, McKesson will now also assume responsibility for the sourcing and distribution of generic pharmaceuticals for Omnicare as part of McKesso
11/27/14 - US COURT REFUSES RANBAXY APPEAL TO BLOCK ANDA NOD
The DC Federal Court of the US has refused to grant restraining order on the appeal of Ranbaxy Laboratories to block Abbreviated New Drug Applications. Ranbaxy had approached the court to restrain US Food. and Drug Administration from granting approval to sell generic versions of Nexium and Valcyte in the US market.
11/26/14 - Global Biosimilars/Follow-on-Biologics Market 2013-2020 - Technology, Types, Applications, Services Analysis of the $35 Billion Market
Dublin- Research and Markets has announced the addition of the "Global Biosimilars/Follow-on-Biologics Market- Research Report, 2013- 2020" report to their offering. Geographically, Biosimilars market is segmented into North America, Europe, Asia-Pacific and LAMEA. Due to favorable regulatory policies designed by the European Medical Association, t
11/26/14 - Overview and Background of Biosimilars 2014: What They are and a Timeline of their Development
Dublin- Research and Markets has announced the addition of the "Overview and Background of Biosimilars 2014: What They are and a Timeline of their Development" report to their offering. In order to keep up with the pace of change in the marketplace, regulatory agencies have been developing updated guidance around the development and approval of bio
11/26/14 - Patent Issued for Microtablet-Based Pharmaceutical Preparation
By a News Reporter-Staff News Editor at Biotech Week A patent by the inventor Rohr, Wolfgang, filed on February 9, 2007, was published online on November 11, 2014, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 8883205 is assigned to Biogenerics Pharma GmbH. The following quote was obtai
11/26/14 - Prof. Yitzhak Peterburg Elected Chairman of Teva's Board of Directors
Teva Pharmaceutical Industries Ltd. today announced that the Board of Directors has elected Professor Yitzhak Peterburg as Chairman, effective January 1, 2015. After an extensive international search, the Board determined that Yitzhak is best placed to provide the leadership and vision we need to strengthen Teva s position as a global player
11/26/14 - Rep. Cummings Introduces Bill to Require Drug Manufacturers to Pay Additional Rebate
Elijah E. Cummings, D- Md., has introduced legislation to "extend the requirement that drug manufacturers that increase prices faster than inflation pay an additional rebate to State Medicaid programs to include manufacturers of generic drugs." For more information about congressional legislation and services offered by Targeted News Service to tra
11/26/14 - Research and Markets: Global Biosimilars/Follow-on-Biologics Market 2013-2020 - Technology, Types, Applications, Services Analysis of the $35 Billion Market
Research and Markets has announced the addition of the "Global Biosimilars/Follow-on-Biologics Market- Research Report, 2013- 2020" report to their offering. Geographically, Biosimilars market is segmented into North America, Europe, Asia-Pacific and LAMEA. Due to favorable regulatory policies designed by the European Medical Association, the Europ
11/26/14 - Research and Markets: Overview and Background of Biosimilars 2014: What They are and a Timeline of their Development
Research and Markets has announced the addition of the "Overview and Background of Biosimilars 2014: What They are and a Timeline of their Development" report to their offering. In order to keep up with the pace of change in the marketplace, regulatory agencies have been developing updated guidance around the development and approval of biosimilars
11/26/14 - Sen. Sander Introduces Bill to Apply Medicaid Additional Requirement to Generic Drug Manufacturers
by MERLY LAPIG Targeted News Service. For more information about congressional legislation and services offered by Targeted News Service to track issues, key words or members of Congress who introduce or co-sponsor legislation, please contact editor@targetednews.com or call 703/ 304-1897.. For more information about Targeted News Service products a
11/26/14 - The People's Pharmacy: Generic drug prices are skyrocketing [Gazette, The (CO)]
An article in the New England Journal of Medicine notes the price of the blood pressure medicine captopril increased more than 2,800 percent between November 2012 and November 2013, from 1.4 cents per pill to 39.9 cents per pill. Doxycycline was first marketed as Vibramycin in 1967. It has long been available as an inexpensive, broad- spectrum gene
11/26/14 - The People's Pharmacy: Generic drug prices are skyrocketing [The Gazette (Colorado Springs, Colo.)]
An article in the New England Journal of Medicine notes the price of the blood pressure medicine captopril increased more than 2,800 percent between November 2012 and November 2013, from 1.4 cents per pill to 39.9 cents per pill. Doxycycline was first marketed as Vibramycin in 1967. It has long been available as an inexpensive, broad- spectrum gene
11/25/14 - Beximco Pharma Becomes First Bangladeshi Company to Receive GMP Approval from Health Canada
Release date- 24112014- Beximco Pharmaceuticals Limited, the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces that it has received GMP approval from the Canadian regulatory authority, Health Canada. Beximco Pharma is the first Bangladeshi company to receive GMP accreditation from...
11/25/14 - Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc.
Breckenridge Pharmaceutical, Inc. announced today that it has entered into a multi-product ANDA agreement with Pii under which Breckenridge and Pii expect to develop and commercialize several new ANDA's. Breckenridge Pharmaceutical, Inc. is a privately-held pharmaceutical marketing, research and development company founded in 1983 that markets a.
11/25/14 - Cuba sells medicines and health technology to more than 50 countries
Havana, Nov 25.- Cuba sells medicines and health technologies to more than 50 countries, including vaccines, generic medications, equipment and diagnostic systems, the official daily Juventud Rebelde reported Tuesday. "About 30 new products from Cuba and a group of generics are being exported to Bolivarian Alliance for the Peoples of Our America m
11/25/14 - DR REDDY'S LAUNCHES CANCER SHOT IN US
Dr Reddy's Laboratories has launched docetaxel injection in the US market after its abbreviated new drug application was approved by the US Food and Drug Administration.
11/25/14 - MALLINCKRODT PLC - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated and combined financial statements and the accompanying notes included in this Annual Report on Form 10- K. The following discussion may contain forward-looking statements that reflect our plans, estimates an
11/25/14 - Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC
Mylan Inc. today confirmed that it and several subsidiaries have been sued by Baxter International, Inc., Baxter Healthcare Corporation and Baxter Healthcare S.A., in connection with the filing of an Abbreviated New Drug Application with the U.S. Food and Drug Administration for Esmolol HCl in Sodium Chloride Injection, 10 mg/ml and 20 mg/ml.
11/25/14 - Research and Markets: Global Oncology Biosimilars Market 2014-2018 with Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, Mylan & Sandoz Dominating
Research and Markets has announced the addition of the "Global Oncology Biosimilars Market 2014-2018" report to their offering. The Global Oncology Biosimilars market to grow at a CAGR of 29.87% over the period 2013-2018.. Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the.
11/25/14 - SUPERNUS PHARMACEUTICALS INC FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits
On November 21, 2014, Supernus Pharmaceuticals, Inc. issued a press release announcing that it sued generic drug makers Zydus Pharmaceuticals Inc. and Cadila Healthcare Limited for infringement of three patents covering its antiepileptic drug Trokendi XR . On November 24, 2014, Supernus Pharmaceuticals, Inc. issued a press release announcing the.
Articles(s): 1 - 25 of 44     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Newest and Most Current Medications in the Treatment of Diabetes
This lesson is supported by:
RxSchool
HIV & AIDS Testing & Reporting Guidelines
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415